EDSA
Edesa Biotech, Inc.Company Information
- Company Name
- Edesa Biotech, Inc.
- CIK
- CIK0001540159
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- EDSA: Nasdaq
- Fiscal Year End
- September 30
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- EDSA
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-03-10
- Last sale
- —
- Shares purchased (TTM)
- 65,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 3,723,060
- Shares outstanding
- 9,007,474
- Ownership
- 41.33%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -12.89%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 10 | 10 | 12 | 11 | 12 | 14 | 2 | 1 | 2 | 3 | 4 | 5 | ||||||
| Accounts And Other Receivables Net Current | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 11 | 10 | 13 | 12 | 13 | 14 | 2 | 2 | 3 | 4 | 5 | 6 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Deposits Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 13 | 12 | 15 | 14 | 15 | 16 | 4 | 4 | 5 | 6 | 8 | 9 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Operating Lease Liability Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 4 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Liabilities Current | 4 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Common Stock Value | 62 | 59 | 58 | 55 | 54 | 54 | 48 | 47 | 47 | 47 | 47 | 47 | ||||||
| Preferred Stock Value | - | - | - | - | - | - | 1 | - | - | - | - | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Stockholders Equity | 9 | 10 | 14 | 12 | 14 | 16 | 2 | 2 | 3 | 4 | 6 | 7 | ||||||
| Additional Paid In Capital | 16 | 16 | 15 | 15 | 14 | 14 | 14 | 14 | 13 | 13 | 13 | 13 | ||||||
| Liabilities | - | - | - | - | - | - | - | 2 | 2 | 2 | 2 | 2 | ||||||
| Long Term Loans Payable | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -78 | -72 | -68 | -66 | -64 | -62 | -60 | -59 | -58 | -56 | -54 | -52 | ||||||
| Capital Units | - | - | - | - | - | - | - | - | - | - | - | 47 | ||||||
Other Commitments | ||||||||||||||||||
| Liabilities And Stockholders Equity | 13 | 12 | 15 | 14 | 15 | 16 | 4 | 4 | 5 | 6 | 8 | 9 | ||||||
| Common Stock No Par Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | ||||||
| Shares Outstanding | 10 | 9 | 8 | 7 | 7 | 7 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | 0 | - | - | - | - | - | ||||||
| Common Stock Shares Issued | 10 | 9 | 8 | 7 | 7 | 7 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialEdesa Biotech, Inc. (EDSA) — SEC Financial Statements & Analysis
Edesa Biotech, Inc. (EDSA) is a pharmaceutical preparations company, incorporated in A1. Edesa Biotech, Inc. trades on Nasdaq as: EDSA. Edesa Biotech, Inc. (EDSA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Edesa Biotech, Inc. carries a market cap of $73.23M, a P/E ratio of -5.19x, a P/B ratio of 8.31x, an enterprise value of $62.90M, and an EV/EBITDA multiple of -4.33x. On profitability, it posts a Return on Equity (ROE) of -122.93%, a Return on Assets (ROA) of -102.46%, and a Return on Invested Capital (ROIC) of -1199.55%. Per share, it reports EPS of $-1.57, free cash flow per share of $-0.99, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 138.24% year-over-year and EPS growth of 85.74% year-over-year. On the balance sheet, it maintains a current ratio of 2.76x, a quick ratio of 2.70x, working capital of $6.87M, a debt-to-equity ratio of 0.44x, a debt ratio of 0.31, free cash flow of $-8.91M (TTM), and net debt of $-10.33M. Figures sourced from SEC EDGAR.
- Market Cap
- $73.23M
- P/E TTM
- -5.19x
- EPS TTM
- $-1.57
- P/B TTM
- 8.31x
- ROE TTM
- -122.93%
- ROA TTM
- -102.46%
- Debt To Equity
- 0.44x
- Free Cash Flow TTM
- $-8.91M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Edesa Biotech, Inc. in?
Edesa Biotech, Inc. (EDSA) operates in the Pharmaceutical Preparations industry.
What exchange does EDSA trade on?
Edesa Biotech, Inc. (EDSA) trades on the Nasdaq.
Where is Edesa Biotech, Inc. incorporated?
Edesa Biotech, Inc. is incorporated in British Columbia, Canada.
When was Edesa Biotech, Inc. (EDSA)'s most recent SEC filing?
Edesa Biotech, Inc. (EDSA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is EDSA's market cap?
Edesa Biotech, Inc. (EDSA) has a market capitalization of $73.23M as of 2026-06-30.
What is EDSA's EPS (earnings per share)?
Edesa Biotech, Inc. (EDSA)'s trailing twelve month EPS is $-1.57 as of 2026-06-30.
What is EDSA's ROE (return on equity)?
Edesa Biotech, Inc. (EDSA)'s trailing twelve month Return on Equity (ROE) is -122.93% as of 2026-06-30.
What is EDSA's ROA (return on assets)?
Edesa Biotech, Inc. (EDSA)'s trailing twelve month Return on Assets (ROA) is -102.46% as of 2026-06-30.
What is EDSA's ROIC (return on invested capital)?
Edesa Biotech, Inc. (EDSA)'s trailing twelve month Return on Invested Capital (ROIC) is -1199.55% as of 2026-03-31.
What is EDSA's EV/EBITDA?
Edesa Biotech, Inc. (EDSA)'s trailing twelve month EV/EBITDA is -4.33x as of 2026-06-30.